Vision and Proprioception Evaluation With Robotics After Stroke
NCT ID: NCT07254949
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
425 participants
OBSERVATIONAL
2026-01-31
2031-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Using robotics to assess neurologic function after a stroke can be very beneficial, as they can measure on the scale of millimetres and milliseconds which can more easily detect subtle deficits in a persons function. Compared to current clinical tools, robotics offer greater objectivity and reliability, as they do not rely on the examiners clinical experience and/or impression. The use of robotics not only offers a more precise measurement, but robotics assessments can be completed in a relatively short amount of time, in comparison to some of the current clinical assessment tools, which can take along time to complete. In addition to robotics, collecting neuroimaging (MRI/CT) will allow us to relate our robotic and eye-tracking measures to neuroanatomical information about the person's stroke. With this data, we will assess how the brain changes post-stroke in relation to the recovery of motor, sensory and visual functions.
This research will: 1) examine the relationship between visual and proprioceptive impairment on motor and eye movement behaviour over time after stroke, and 2) identify neuroanatomical correlates of visual, proprioceptive and sensory integrative dysfunction that impact motor recovery after stroke and examine the ability of regional damage and network disruption to predict recovery.
Objectives:
1. Determine the impact of visual field loss and visual neglect in stroke survivors with impaired movement over the first 6 months post-stroke.
2. Identify the impact of Proprioceptive Impairment and Sensory Integration Impairment on recovery post-stroke using robotics and eye tracking.
3. Understand the impact of damage to neuroanatomic structures involved in vision, proprioception and sensory integration on motor recovery using MRI after stroke.
The VIPERS study is recruiting both stroke and control participants. Stroke participants are recruited within the first 28 days post-stroke and are assessed longitudinally across the first 6-months post-stroke (four study timepoints). Control participants just complete a single session.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke
Stroke Participants - Individuals with first time stroke
No interventions assigned to this group
Control
Control Participants - Individuals not suffering stroke or other neurological disorders
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First clinical diagnosis of stroke
* No recent muscle skeletal injuries to the arms, neck, or back
* No history of other neurological disease/injury (Ie. MS, Parkinson's, Brain Tumour, etc.)
* Corrected vision 20/50 or better
* Able to follow multi-step commands.
* Living independently prior to stroke
* Can consent to participate in research
* 18 years of age or older
* No history stroke, or Trans Ischemic Attack (TIA)
* No recent muscle skeletal injures to the arms, neck, or back
* No history of other neurological disease/ injury (Ie. MS, Parkinson's, Brain Tumour, etc)
* No pre-stroke history of eye movement disorders
* Corrected vision 20/50 or better
* Able to follow multi-step commands
* Can consent to participate in research
Exclusion Criteria
* Symptomatic medical conditions that would interfere with participation (e.g. uncontrolled angina)
* Contraindications to Magnetic Resonance Imaging (MRI)
* Pre-stroke history of visual field/oculomotor abnormalities.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Sean Dukelow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Sean Dukelow
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carewest Dr. Vernon Fanning Centre
Calgary, Alberta, Canada
Foothills Medical Centre
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Rachel Stone
Role: primary
Rachel Stone
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
197953
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
REB25-1170
Identifier Type: -
Identifier Source: org_study_id